BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6296002)

  • 21. [Therapeutic effect of ceftizoxime on infection in patients with lung cancer].
    Hiraki S; Ohnoshi T; Tamura M; Kawahara S; Miyamoto H; Nishii K; Kimura I
    Jpn J Antibiot; 1986 Jan; 39(1):87-93. PubMed ID: 3009911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
    Cohen E; Mogabgab WJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():253-60. PubMed ID: 6296017
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical studies of the efficacy and tolerance of cefotaxime, ceftizoxime and ceftriaxone in patients with complicated urinary tract infections].
    Westenfelder M; Pelz K
    Infection; 1983; 11(6):296-301. PubMed ID: 6321356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized comparative trial with ceftizoxime and cefotaxime in urinary tract infections.
    Tripi M; Pavone-Macaluso M; Giammanco A; Carella G
    Int Urol Nephrol; 1985; 17(3):195-202. PubMed ID: 3910604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of ceftizoxime on various infections in patients with underlying diseases].
    Nakatomi M; Sakugawa H; Shimoji K; Kaneshima H; Aragaki T; Urasaki M; Irabu Y; Ogimi T; Makishi K; Kinjo Y
    Jpn J Antibiot; 1984 May; 37(5):817-22. PubMed ID: 6090723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of ceftizoxime in neonates.
    Yamauchi T; Hill DE; Steele RW
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():297-301. PubMed ID: 6296024
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of ceftizoxime intravenous administration in severe infections associated with hematologic disorders. Niigata Infection Study Group].
    Moriyama Y; Shibata A; Ito M; Iizumi T; Watabe T; Sato M; Kurokawa I; Sugiyama K; Sanada M; Nakamura T
    Jpn J Antibiot; 1986 Mar; 39(3):807-14. PubMed ID: 3461176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of ceftizoxime in treating infections due to organisms resistant to other antibiotics.
    Neu HC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():193-9. PubMed ID: 6296006
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ceftizoxime in the treatment of infective pathology in the elderly].
    Garotta F; Magni O; Meinardi G
    Boll Chim Farm; 1986 Dec; 125(12):127S-131S. PubMed ID: 3473994
    [No Abstract]   [Full Text] [Related]  

  • 30. A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections.
    Harding G; Vincelette J; Rachlis A; Fong I; Mandell L; Feld R; Bailey D
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():191-2. PubMed ID: 6296005
    [No Abstract]   [Full Text] [Related]  

  • 31. Cefoperazone for the treatment of infections in patients with cancer.
    Bolivar R; Fainstein V; Elting L; Bodey GP
    Rev Infect Dis; 1983; 5 Suppl 1():S181-7. PubMed ID: 6221389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effectiveness of ceftizoxime in the treatment of respiratory tract infections].
    Gialdroni Grassi G; Manara G; Mangiarotti P; Navone A
    G Ital Chemioter; 1982; 29(1):49-54. PubMed ID: 6309599
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic effectiveness of ceftizoxime on severe infections associated with hematologic disorders].
    Kanamaru A; Nagai K; Masaoka T; Shibata H; Kitani T; Taniguchi N; Horiuchi A; Hasegawa H; Kawagoe H; Hirata M
    Jpn J Antibiot; 1984 Jan; 37(1):136-44. PubMed ID: 6328059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fundamental and clinical studies on ceftizoxime (author's transl)].
    Okada T; Hirao F; Furukawa S
    Jpn J Antibiot; 1982 Jan; 35(1):91-104. PubMed ID: 6279917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefmenoxime therapy of serious bacterial infections.
    Gombert ME; Glasser LA; Eng RH
    Antimicrob Agents Chemother; 1984 Apr; 25(4):510-2. PubMed ID: 6329082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with ceftizoxime in the pediatric field (author's transl)].
    Hosoda T; Tomimatsu H; Ohara K; Okamoto T
    Jpn J Antibiot; 1982 Jan; 35(1):81-90. PubMed ID: 6279915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftizoxime sodium (Cefizox).
    Med Lett Drugs Ther; 1983 Dec; 25(650):109-10. PubMed ID: 6318059
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical effects of ceftizoxime suppositories in pediatric infections].
    Furukawa S; Okada T
    Jpn J Antibiot; 1985 Oct; 38(10):2943-51. PubMed ID: 3908729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A selective clinical trial of ceftizoxime.
    Anania WC; Chinkes SL; Rosen RC; Turner PR; Helfand AE
    J Am Podiatr Med Assoc; 1987 Dec; 77(12):648-52. PubMed ID: 3323468
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical investigation of ceftizoxime sodium suppositories in pediatric infections].
    Tomimasu K; Hayashi K; Tsuji Y
    Jpn J Antibiot; 1985 Oct; 38(10):3065-9. PubMed ID: 3908730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.